Clinic
Bsa Hospital LLC
Bsa Hospital LLC was paid $4.96M by Medicaid between May 2018 and Dec 2024, across 124 billing codes. Its largest line is 99284, emergency room visit (serious) — 47% of everything it billed.
33Billing provider infoBSA HOSPITAL LLC
AMARILLO, TX 79106
AMARILLO, TX 79106
33aNPI1407191984assigned 12/10/2012
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$4.96M
24GClaims139,170
24DCodes billed124
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#78 of 320
Median peer was paid$205K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PETROVICH, STEPHEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 134 | $978.22 | |
| 2019 | 185 | $1K | |
| 2020 | 1,117 | $56K | |
| 2021 | 37,556 | $869K | |
| 2022 | 41,147 | $1.05M | |
| 2023 | 37,713 | $2.10M | |
| 2024incomplete | 21,318 | $881K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 47% | 7,440 | 6,979 | $2.34M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 3,804 | 3,432 | $829K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 12% | 690 | 658 | $576K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.8% | 6,555 | 6,245 | $438K |
| 87631 | 2.7% | 1,034 | 984 | $134K | |
| 80053 | Comprehensive metabolic panel | 1.8% | 13,780 | 11,254 | $87K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 17,840 | 14,384 | $80K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 655 | 630 | $58K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.0% | 891 | 847 | $50K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 500 | 478 | $37K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 908 | 873 | $36K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,984 | 1,837 | $31K |
112 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,406 | $27K |
| 84702 | <1% | 1,534 | $24K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,545 | $19K |
| 81001 | <1% | 6,837 | $17K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,475 | $13K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 491 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 21,375 | $12K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,361 | $9K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 295 | $8K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,277 | $7K |
| 80076 | <1% | 1,040 | $7K | |
| 83690 | <1% | 1,730 | $6K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 115 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,995 | $6K |
| 83880 | <1% | 1,365 | $5K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,208 | $5K |
| 84703 | <1% | 769 | $4K | |
| 84484 | <1% | 1,582 | $4K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,670 | $4K |
| 76801 | <1% | 49 | $4K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 49 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,027 | $4K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 64 | $4K |
| 83735 | <1% | 1,719 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 266 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 354 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 534 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 34 | $2K |
| 86850 | <1% | 404 | $2K | |
| 80306 | <1% | 346 | $2K | |
| 94761 | <1% | 302 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 361 | $1K |
| 83605 | <1% | 395 | $1K | |
| 85610 | <1% | 1,603 | $1K | |
| 85730 | <1% | 1,011 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 48 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 805 | $939.43 |
| 87077 | <1% | 1,180 | $933.12 | |
| 87186 | <1% | 1,099 | $916.31 | |
| 86901 | <1% | 424 | $897.65 | |
| 86900 | <1% | 424 | $897.49 | |
| 84100 | <1% | 293 | $866.06 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,508 | $801.79 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 528 | $767.99 |
| 97597 | <1% | 452 | $732.91 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 110 | $695.38 |
| 86140 | <1% | 761 | $691.99 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 12 | $679.97 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 39 | $637.65 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 12 | $636.46 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 979 | $632.10 |
| CP008 | <1% | 14 | $576.93 | |
| 87641 | <1% | 131 | $555.75 | |
| 87640 | <1% | 131 | $555.75 | |
| 80061 | Lipid panel | <1% | 1,283 | $542.66 |
| 84145 | <1% | 223 | $514.66 | |
| 82962 | <1% | 1,789 | $430.17 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 24 | $421.30 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,473 | $414.56 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 263 | $385.95 |
| 82607 | <1% | 199 | $379.84 | |
| 84439 | <1% | 448 | $372.50 | |
| 86645 | <1% | 12 | $365.42 | |
| 86663 | <1% | 12 | $362.48 | |
| 93971 | <1% | 13 | $360.45 | |
| 86376 | <1% | 13 | $358.75 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 339 | $317.16 |
| 86644 | <1% | 12 | $312.08 | |
| 87040 | <1% | 169 | $310.49 | |
| 76937 | <1% | 33 | $308.24 | |
| 87071 | <1% | 169 | $302.86 | |
| 82728 | <1% | 12 | $295.59 | |
| 84480 | <1% | 12 | $286.97 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 86 | $269.59 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 154 | $268.85 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 83 | $268.10 |
| 86038 | <1% | 12 | $262.39 | |
| 85379 | <1% | 128 | $228.40 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 666 | $221.61 |
| 94664 | <1% | 12 | $152.61 | |
| 83540 | <1% | 73 | $151.03 | |
| 80164 | <1% | 394 | $144.11 | |
| 84436 | <1% | 29 | $138.99 | |
| 99152 | <1% | 59 | $96.40 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 15 | $86.68 |
| 80177 | <1% | 56 | $77.38 | |
| 87205 | <1% | 149 | $76.04 | |
| 85652 | <1% | 195 | $64.75 | |
| 82565 | <1% | 117 | $61.18 | |
| J2704 | Injection, propofol, 10 mg | <1% | 343 | $60.28 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 89 | $50.36 |
| C1769 | Guide wire | <1% | 125 | $49.13 |
| 82550 | <1% | 58 | $43.81 | |
| 84481 | <1% | 48 | $42.69 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 306 | $40.02 |
| 85027 | <1% | 179 | $38.29 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 14 | $34.42 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 42 | $33.50 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 241 | $28.61 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 69 | $21.71 |
| 82140 | <1% | 16 | $7.43 | |
| 83550 | <1% | 46 | $7.34 | |
| A9270 | Non-covered item or service | <1% | 1,137 | $0.43 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 891 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 83 | $0.00 |
| 82746 | 0% | 25 | $0.00 | |
| 87147 | 0% | 17 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 0% | 32 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 24 | $0.00 |
| 36410 | 0% | 15 | $0.00 | |
| 96376 | 0% | 13 | $0.00 | |
| 83615 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPETROVICH, STEPHEN (SVP)
Parent organizationBSA HEALTH SYSTEM OF AMARILLO LLC
| Provider | Location | Paid |
|---|---|---|
| Lovelace Health System, LLC | Albuquerque, NM | $57.71M |
| Lovelace Health System LLC | Albuquerque, NM | $45.27M |
| Southwest Medical Associates, LLC | Albuquerque, NM | $41.40M |
| Lovelace Health System, LLC | Albuquerque, NM | $31.24M |
| Lovelace Health System LLC | Roswell, NM | $20.13M |
| Jacksonville Hospital LLC | Jacksonville, TX | $9.41M |
| Henderson Hospital, LLC | Henderson, TX | $8.52M |
| Athens Hospital, LLC | Athens, TX | $8.32M |
| Etmc Physician Group INC. | Tyler, TX | $8.03M |
| Tyler Regional Hospital LLC | Tyler, TX | $7.94M |
| Lovelace UNM Rehabilitation Hospital LLC | Albuquerque, NM | $6.30M |
| Pocatello Hospital LLC | Pocatello, ID | $6.11M |
| Jacksonville Hospital LLC | Jacksonville, TX | $5.93M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $5.61M |
| Pittsburg Hospital LLC | Pittsburg, TX | $4.83M |
| Ahs Claremore Regional Hospital, LLC. | Claremore, OK | $4.81M |
| Ahs Henryetta Hospital LLC | Henryetta, OK | $4.27M |
| Pittsburg Hospital LLC | Pittsburg, TX | $3.98M |
| Topeka Hospital, LLC | Topeka, KS | $3.94M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $3.76M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.